An Interim Monitoring Visit (IMV) is a scheduled on-site evaluation conducted during the course of a clinical trial. It is performed by a clinical research associate or monitor to assess the progress of the study, ensure compliance with protocols, and verify the accuracy and completeness of data collected.
IMVs are crucial for maintaining the quality and integrity of clinical research. During these visits, monitors review source documents, case report forms, and other study-related materials to identify and address any issues or discrepancies that may have arisen since the previous visit.
Interim Monitoring Visits are essential for ensuring the ongoing quality and integrity of clinical trials. These visits allow for timely identification and correction of protocol deviations, data discrepancies, and other issues that could potentially compromise the validity of study results.
IMVs also play a crucial role in protecting the rights and safety of study participants. By regularly verifying adherence to ethical guidelines and regulatory requirements, these visits help maintain the highest standards of patient care and data management throughout the duration of a clinical trial.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant